Statistical modeling using preoperative prognostic variables in predicting extracapsular extension and progression after radical prostatectomy for prostate cancer

被引:11
作者
Bauer, JJ [1 ]
Connelly, RR [1 ]
Seterhenn, IA [1 ]
Srivastava, S [1 ]
McLeod, DG [1 ]
Moul, JW [1 ]
机构
[1] Walter Reed Army Med Ctr, Dept Surg, Urol Serv, Washington, DC 20307 USA
关键词
D O I
10.1093/milmed/163.9.615
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To predict the risk of extracapsular extension and postoperative recurrence before radical prostatectomy (RP) for prostate cancer. Methods: We performed multivariate Cox regression analysis on preoperative variables in 260 clinically localized prostate cancer patients who underwent RP. With these data, we constructed a relative risk of recurrence (R-r) equation and an equation to predict the probability of extracapsular extension (P-ECE) before RP. Results: R-r is calculated as exp[(0.47 x race + 0.14 x PSA(ST)) + (0.13 x worst biopsy Gleason sum) + (1.03 x stage Tlc) + (1.55 x stage T2b,c)], where PSA(ST) indicates a sigmoidal transformation of prostate-specific antigen. P-ECE is calculated as 1/[1 + exp(-Z)], where Z = -2.47 + 0.15 (PSA(ST)) + 0.31 (worst biopsy Gleason sum) + 0.18 (race) + 0.16 (stage Tlc) + 0.38 (stage T2b,c). Conclusion: These two equations can be used preoperatively to predict the probability of extracapsular disease and the risk of prostate-specific antigen recurrence in patients undergoing RP.
引用
收藏
页码:615 / 619
页数:5
相关论文
共 26 条
  • [1] [Anonymous], 1980, Histological typing of prostate tumours / F. K. Mostofi, in collaboration with I. Sesterhenn
  • [2] [Anonymous], UROLOGIC PATHOLOGY
  • [3] Biostatistical modeling using traditional preoperative and pathological prognostic variables in the selection of men at high risk for disease recurrence after radical prostatectomy for prostate cancer
    Bauer, JJ
    Connelly, RR
    Seterhenn, IA
    Deausen, J
    Srivastava, S
    McLeod, DG
    Moul, JW
    [J]. JOURNAL OF UROLOGY, 1998, 159 (03) : 929 - 933
  • [4] Bauer JJ, 1995, CLIN CANCER RES, V1, P1295
  • [5] Elevated levels of apoptosis regulator proteins p53 and bcl-2 are independent prognostic biomarkers in surgically treated clinically localized prostate cancer
    Bauer, JJ
    Sesterhenn, IA
    Mostofi, FK
    McLeod, DG
    Srivastava, S
    Moul, JW
    [J]. JOURNAL OF UROLOGY, 1996, 156 (04) : 1511 - 1516
  • [6] Ki-67 expression is a prognostic marker of prostate cancer recurrence after radical prostatectomy
    Bettencourt, MC
    Bauer, JJ
    Sesterhenn, IA
    Mostofi, FK
    McLeod, DG
    Moul, JW
    [J]. JOURNAL OF UROLOGY, 1996, 156 (03) : 1064 - 1068
  • [7] STATISTICAL-METHODS FOR CENSORED SURVIVAL-DATA
    BRESLOW, N
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1979, 32 (OCT) : 181 - 192
  • [8] COX DR, 1972, J R STAT SOC B, V34, P187
  • [9] A MULTIVARIABLE ANALYSIS OF CLINICAL FACTORS PREDICTING FOR PATHOLOGICAL FEATURES ASSOCIATED WITH LOCAL FAILURE AFTER RADICAL PROSTATECTOMY FOR PROSTATE-CANCER
    DAMICO, AV
    WHITTINGTON, R
    MALKOWICZ, SB
    SCHNALL, M
    TOMASZEWSKI, J
    SCHULTZ, D
    KAO, G
    VANARSDALEN, K
    WEIN, A
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 30 (02): : 293 - 302
  • [10] EPSTEIN JI, 1993, CANCER-AM CANCER SOC, V71, P3582, DOI 10.1002/1097-0142(19930601)71:11<3582::AID-CNCR2820711120>3.0.CO